Flipping the Bird: Elon vs Twitter | Extremely Hardcore | 4
After Elon decimates the workforce in one fell swoop, chaos reigns supreme. Will Elon's dreams for a free and open Twitter turn into everyone's worst nightmare?Be the first to know about Wondery’s new...
16 Jul 202534min
Flipping the Bird: Elon vs Twitter | Chief Twit | 3
Elon Musk seals his purchase of Twitter with a tweet: ""The bird is freed."" But everyone inside of Twitter soon starts to worry, will the bird soon be dead?Be the first to know about Wondery’s newest...
11 Jul 202534min
Flipping the Bird: Elon vs Twitter | I Am Supposed to Believe This Man is a Genius? | 2
Elon Musk makes the Twitter board an offer they can’t refuse — a $44 billion offer, to be exact. But this won’t be an easy marriage. No sooner does Twitter accept than Elon starts raising doubts. Publ...
10 Jul 202533min
Flipping the Bird: Elon vs Twitter | Maximum Amazing | 1
Twitter is at a crossroads. Its founder, Jack Dorsey, has stepped down from his role as CEO. The social media heavyweight is also under fire for alleged bias, censorship, and the roving army of bot ac...
9 Jul 202529min
Rebuilding LEGO | Brick to the Future | 2
It’s late 2003 and LEGO’s turnaround strategy has failed. It’s hurtling towards bankruptcy. Its only hope now is a three-man shadow leadership team. And they’re about to learn that the problems at LEG...
2 Jul 202540min
Rebuilding LEGO | A Burning Platform | 1
It’s early 1997, and after decades of success, LEGO is rocked by a sudden collapse in its profit. To recover, the Danish toy manufacturer jacks up its innovation efforts. But can it deliver a company-...
25 Jun 202541min
23andMe's Fatal Flaw | Guess Who’s Back | 3
Just when it looked like 23andMe was selling to Regeneron Pharmaceuticals, founder Anne Wojcicki placed a bid through her new nonprofit in an attempt to win it back at the eleventh hour. Lila MacLella...
19 Jun 202537min
23andMe's Fatal Flaw | Defying Gravity? | 2
Plagued by low sales of its genetic tests, 23andMe adopts a bold new plan: slash prices and enter the pharmaceutical industry. But with investors nervous, can CEO Anne Wojcicki keep the show going lon...
18 Jun 202539min
